Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Elective CABG Surgery
NCT02122484Phase 4Completed
- Sponsor
- G. Gennimatas General Hospital
- Start
- Nov 2013
- Primary completion
- Jun 2014
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in reperfusion injury (IRI), sponsored by G. Gennimatas General Hospital. Started Nov 2013; status: completed.
02
Drugs
colchicine
03
Conditions
reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT02122484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02122484.